BioCentury
ARTICLE | Company News

Kite Pharma, Tel Aviv Sourasky Medical Center deal

February 16, 2015 8:00 AM UTC

Kite and the center expanded a deal to develop chimeric antigen receptor (CAR) T cell therapies to treat various tumor types. The parties could not be reached for details. ...